RNA helicase DDX24 stabilizes LAMB1 to promote hepatocellular carcinoma progression
Tianze Liu,Hairun Gan,Simeng He,Jia Deng,Xinyan Hu,Luting Li,Li Cai,Jianzhong He,Haoyu Long,Jianxun Cai,Hanjie Li,Qianqian Zhang,Lijie Wang,Fangbin Chen,Yuming Chen,Haopei Zhang,Jian Li,Lukun Yang,Ye Liu,Jian-Hua Yang,Dong-Ming Kuang,Pengfei Pang,Huanhuan He,Hong Shan,JianZhong He,Jianhua Yang
DOI: https://doi.org/10.1158/0008-5472.can-21-3748
IF: 11.2
2022-06-30
Cancer Research
Abstract:Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies. Elucidating the underlying mechanisms of this disease could provide new therapeutic strategies for treating HCC. Here, we identified a novel role of DEAD-box helicase 24 (DDX24), a member of the DEAD-box protein family, in promoting HCC progression. DDX24 levels were significantly elevated in HCC tissues and were associated with poor prognosis of HCC. Overexpression of DDX24 promoted HCC migration and proliferation in vitro and in vivo, whereas suppression of DDX24 inhibited both functions. Mechanistically, DDX24 bound the mRNA618-624nt of laminin subunit beta 1 (LAMB1) and increased its stability in a manner dependent upon the interaction between nucleolin (NCL) and the C-terminal region of DDX24. Moreover, RFX8 was identified as a DDX24 promoter-binding protein that transcriptionally upregulated DDX24 expression. Collectively, these findings demonstrate that the RFX8/DDX24/LAMB1 axis promotes HCC progression, providing potential therapeutic targets for HCC.
oncology